14 November (Day 2)

---

Day 2, 14 November 2019

 

 

Session 3. Business of cell & gene therapy

Chair: Steve Oh, Bioprocessing Technology Institute, Singapore

 

Plenary talk

Wen Bo Wang, Fate Therapeutics, USA  

 

Plenary talk

Mayasari Lim, RoosterBio Inc, USA  

 

Development of an injectable cartilage gel using chondrogenic progenitor cells

Bryan Choi, ATEMs, Korea  

 

Plenary talk

TBA, Stemcell Technologies, Canada

 

Short talk selected from abstracts

 

Short talk selected from abstracts

 

MORNING TEA BREAK                 

 

Plenary talk

Tony Lee, Medipost, Korea  

 

Plenary talk

Xiangliang Lin

Esco Aster, Singapore  

 

Plenary talk

Phan Thao Thang, Cell Research Corp, Singapore   

 

Plenary talk

TBA

 

Panel discussion

Panellists: TBA

 

LUNCH BREAK                 

Session 4. Responsible pathways to translation with cell therapies

Chair: Tamra Lysaght, National University of Singapore

 

Introduction

Tamra Lysaght, National University of Singapore  

 

Plenary talk

Cameron Stewart, University of Sydney, Australia   

 

The oversight of clinical innovation in a medical marketplace

Wendy Lipworth, University of Sydney, Australia   

 

Plenary talk

Mohammad Firdaus Bin Abdul Aziz, University of Malaya, Malaysia  

 

Plenary talk

Lee Lee Ong, HSA, Singapore  

 

Short talk selected from abstracts

 

AFTERNOON TEA BREAK                       

 

Plenary talk

Tamra Lysaght, Centre for Biomedical Ethics, National University of Singapore  

 

Plenary talk

Mickey Koh, St George’s Hospital, UK  

 

Panel discussion

Panellists: TBA

 

 

KEYNOTE LECTURE

The evolution and challenges introducing cell-based therapies into burn care and scar therapy

Fiona Wood, Royal Perth Hospital, Australia

 

END OF THE DAY 2                        

 

---

Jointly Organized by:
​